Cargando…
Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics
Biotherapeutics may contain a multitude of different post-translational modifications (PTMs) that need to be assessed and possibly monitored and controlled to ensure reproducible product quality. During early development of biotherapeutics, unexpected PTMs might be prevented by in silico identificat...
Autores principales: | Tyshchuk, Oksana, Gstöttner, Christoph, Funk, Dennis, Nicolardi, Simone, Frost, Stefan, Klostermann, Stefan, Becker, Tim, Jolkver, Elena, Schumacher, Felix, Koller, Claudia Ferrara, Völger, Hans Rainer, Wuhrer, Manfred, Bulau, Patrick, Mølhøj, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748591/ https://www.ncbi.nlm.nih.gov/pubmed/31339437 http://dx.doi.org/10.1080/19420862.2019.1635865 |
Ejemplares similares
-
Detection of a phosphorylated glycine-serine linker in an IgG-based fusion protein
por: Tyshchuk, Oksana, et al.
Publicado: (2016) -
Metabolic Profiling of CHO Cells during the Production of Biotherapeutics
por: Coulet, Mathilde, et al.
Publicado: (2022) -
Functional genetic encoding of sulfotyrosine in mammalian cells
por: He, Xinyuan, et al.
Publicado: (2020) -
Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space
por: Ziarek, Joshua J., et al.
Publicado: (2011) -
CCR7 Sulfotyrosine Enhances CCL21 Binding
por: Phillips, Andrew J., et al.
Publicado: (2017)